Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis?

Publisher： Karger

E-ISSN： 1421-9751|137|4|244-245

ISSN： 0008-6312

Source： Cardiology, Vol.137, Iss.4, 2017-05, pp. : 244-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Acute Coronary Stent Thrombosis in Modern Era: Etiology, Treatment, and Prognosis

By  

Cardiology, Vol. 137, Iss. 4, 2017-05 ,pp. : 246-255

Karger

Access to resources Recommend Favorite

Subacute Stent Thrombosis Occurring More Than One Month after Implantation for Acute Myocardial Infarction

By  

Cardiology, Vol. 90, Iss. 4, 1999-03 ,pp. : 305-308

Karger

Access to resources Recommend Favorite

Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis

By  

Cardiology, Vol. 130, Iss. 2, 2015-01 ,pp. : 96-105

Karger

Access to resources Recommend Favorite

New‐generation drug‐eluting stents reduce stent thrombosis and myocardial infarction: A propensity‐score‐adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia‐Romagna)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 5, 2015-04 ,pp. : 797-806

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Promyelocytic Leukemia-Associated Thrombosis

By  

Acta Haematologica, Vol. 130, Iss. 1, 2013-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite